MetaVia Competitors
| MTVA Stock | 1.90 0.41 17.75% |
MetaVia vs Collplant Biotechnologies Correlation
Average diversification
The correlation between MetaVia and CLGN is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MetaVia and CLGN in the same portfolio, assuming nothing else is changed.
Moving together with MetaVia Stock
Moving against MetaVia Stock
| 0.71 | ENGN | enGene Holdings Common | PairCorr |
| 0.62 | DSGN | Design Therapeutics | PairCorr |
| 0.53 | ALT | Altimmune | PairCorr |
| 0.43 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.39 | 63E | ONWARD MEDICAL BV | PairCorr |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MetaVia's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
MetaVia Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between MetaVia and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of MetaVia and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of MetaVia does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between MetaVia Stock performing well and MetaVia Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MetaVia's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| LSTA | 4.13 | 1.17 | 0.32 | 0.92 | 2.76 | 5.58 | 88.09 | |||
| NCNA | 3.35 | (0.67) | 0.00 | (0.39) | 0.00 | 6.97 | 16.72 | |||
| XCUR | 5.85 | 0.40 | 0.03 | (0.27) | 8.60 | 21.22 | 63.80 | |||
| ENLV | 3.97 | 0.11 | 0.02 | 0.20 | 4.34 | 8.57 | 24.21 | |||
| KLTO | 4.47 | (1.18) | 0.00 | (0.30) | 0.00 | 10.34 | 28.13 | |||
| PASG | 5.88 | 0.58 | 0.12 | 0.17 | 6.35 | 14.59 | 58.13 | |||
| CLSD | 6.75 | (2.95) | 0.00 | 3.93 | 0.00 | 7.96 | 83.67 | |||
| CASI | 3.72 | (0.51) | 0.00 | (0.32) | 0.00 | 5.88 | 32.11 | |||
| SONN | 10.16 | (0.26) | 0.00 | (0.92) | 0.00 | 19.48 | 69.59 | |||
| CLGN | 3.73 | (0.32) | 0.00 | 1.08 | 0.00 | 8.51 | 32.88 |
Cross Equities Net Income Analysis
Compare MetaVia and related stocks such as Lisata Therapeutics, NuCana PLC, and Exicure Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LSTA | (2.7 M) | (47.1 M) | (54.8 M) | (39 M) | (54.9 M) | (80.9 M) | (32.7 M) | 23 M | (16.2 M) | (20.1 M) | (8.2 M) | (27.5 M) | (54.2 M) | (20.8 M) | (20 M) | (18 M) | (18.9 M) |
| NCNA | (6.2 K) | (6.2 K) | (6.2 K) | (6.2 K) | (6.2 K) | (5.3 M) | (6 M) | (23.1 M) | (13.8 M) | (21.4 M) | (30.7 M) | (40.5 M) | (32 M) | (27.6 M) | (19 M) | (17.1 M) | (18 M) |
| XCUR | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (16.9 M) | (11 M) | (22.4 M) | (26.3 M) | (24.7 M) | (64.1 M) | (2.6 M) | (16.9 M) | (9.7 M) | (8.7 M) | (9.2 M) |
| ENLV | (229 K) | (229 K) | (229 K) | (1.1 M) | (7 M) | (15.4 M) | (16 M) | (5.9 M) | (4.9 M) | (9.4 M) | (11.8 M) | (14.5 M) | (31.1 M) | (29.1 M) | (15 M) | (13.5 M) | (14.2 M) |
| KLTO | (913) | (913) | (913) | (913) | (913) | (913) | (913) | (913) | (913) | (913) | (913) | (1.1 M) | (598.6 K) | (707.5 K) | (6.2 M) | (5.5 M) | (5.3 M) |
| PASG | (12.8 M) | (12.8 M) | (12.8 M) | (12.8 M) | (12.8 M) | (12.8 M) | (12.8 M) | (12.8 M) | (12.8 M) | (45.6 M) | (112.2 M) | (185.4 M) | (136.1 M) | (102.1 M) | (64.8 M) | (58.3 M) | (61.2 M) |
| CASI | (20 K) | (4.6 M) | (14.5 M) | (5.7 M) | (26.2 M) | (7.2 M) | (9.5 M) | (10.8 M) | (27.5 M) | (45.4 M) | (48.3 M) | (36.7 M) | (41 M) | (26.9 M) | (39.3 M) | (35.3 M) | (33.6 M) |
| CLGN | (4.5 M) | (4.5 M) | (4.5 M) | (4.6 M) | (3.6 M) | (4.8 M) | (7.3 M) | (5.8 M) | (6.2 M) | (11.2 M) | (5.8 M) | 237 K | (16.9 M) | (7 M) | (16.6 M) | (14.9 M) | (14.2 M) |
MetaVia and related stocks such as Lisata Therapeutics, NuCana PLC, and Exicure Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in MetaVia financial statement analysis. It represents the amount of money remaining after all of MetaVia operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.MetaVia Competitive Analysis
The better you understand MetaVia competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, MetaVia's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across MetaVia's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
MetaVia Competition Performance Charts
Five steps to successful analysis of MetaVia Competition
MetaVia's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by MetaVia in relation to its competition. MetaVia's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of MetaVia in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact MetaVia's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to MetaVia, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your MetaVia position
In addition to having MetaVia in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Social Domain Thematic Idea Now
Social Domain
New or established large and mid-sized companies that are involved in the social media industry, including entities that provide web-based or mobile media applications and services across across large segment of population in multiple geographical areas. The Social Domain theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Social Domain Theme or any other thematic opportunities.
| View All Next | Launch |
Check out MetaVia Correlation with its peers. For information on how to trade MetaVia Stock refer to our How to Trade MetaVia Stock guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MetaVia. Expected growth trajectory for MetaVia significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive MetaVia assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding MetaVia requires distinguishing between market price and book value, where the latter reflects MetaVia's accounting equity. The concept of intrinsic value - what MetaVia's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push MetaVia's price substantially above or below its fundamental value.
Understanding that MetaVia's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MetaVia represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, MetaVia's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.